---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022580"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:10:01.247075+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q2 revenue surges 95% to $8.8M; net loss narrows to $3.8M

## Summary
- Revenue $8.8M (+95% YoY, +18% seq); system revenue $3.0M (vs $0.2M), recurring $5.8M (+35% YoY).
- Net loss $3.8M vs $5.8M; adjusted net loss $1.3M vs $3.3M; gross margin 52%.
- Cash $7.0M at June 30; July $12.5M financing closed; pro forma cash $18.8M, no debt.
- Guidance: double-digit FY2025 revenue growth; Q4 recurring ~$7M; system $2-3M/quarter.
- FDA clearance for MAGiC Sweep catheter; initial sales in Q2; further approvals expected near-term.

## SEC filing metadata
- accession: 0001641172-25-022580
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/0001641172-25-022580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022580
- JSON: https://secwatch.observer/filing/0001641172-25-022580.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.